Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate
Heather J. Bax(King's College London), Sophia N. Karagiannis(King's College London), Giulia Pellizzari(King's College London), Chara Stavraka(King's College London), Sidath Katugampola(Cancer Research UK), Charleen Chan Wah Hak(Institute of Cancer Research), James Spicer(King's College London), Debra H. Josephs(Guy's and St Thomas' NHS Foundation Trust), Atousa Khiabany(King's College London), Christopher J. Corrigan(King's College London), Cheryl Gillett(King's College London), Kristina M. Ilieva(King's College London), A. Winship(Guy's and St Thomas' NHS Foundation Trust), Alexandra Robinson(Guy's Hospital), Claire Barton(University of Hertfordshire), Stephen J. Till(Guy's Hospital), Hannah J. Gould(King's College London), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Sharmistha Ghosh(Guy's and St Thomas' NHS Foundation Trust), Cristina Naceur‐Lombardelli(Cancer Research UK), Sarah E. Pinder(St Thomas' Hospital), Natalie Woodman(London Cancer)
Cited by 22
Related Papers
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Lung adenocarcinoma promotion by air pollutants
|Nature|2023|751
<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
|Cancer Research|2010|740